Table 2.
CpG probe | Chr | Position (bps) | Genomic feature | p-value | q-value | Gene* | Direction† |
---|---|---|---|---|---|---|---|
cg01624068 | 13 | 113,137,799 | intergenic | 1.35×10−9 | 2.68×10−4 | TUBGCP3 | ↑ |
cg10506070 | 5 | 114,502,492 | intergenic | 1.60×10−9 | 2.68×10−4 | ↑ | |
cg00391025 | 3 | 100,427,239 | intergenic | 2.13×10−9 | 2.68×10−4 | ↑ | |
cg19734937 | 2 | 63,855,048 | intergenic | 2.58×10−9 | 2.68×10−4 | ↑ | |
cg25871696 | 13 | 81,914,087 | intergenic | 3.03×10−9 | 2.68×10−4 | ↑ | |
cg26102082 | 17 | 47,590,272 | exons | 7.70×10−9 | 5.67×10−4 | NGFR | ↓ |
cg06060962 | 6 | 32,515,150 | introns | 1.01×10−8 | 5.75×10−4 | HLA-DRB5 | ↑ |
cg02226953 | 7 | 150,525,449 | intergenic | 1.04×10−8 | 5.75×10−4 | ↑ | |
cg03660952 | 11 | 2,644,418 | exons | 1.21×10−8 | 5.93×10−4 | KCNQ1OT1 | ↑ |
cg23968456 | 10 | 73,521,631 | exons | 1.87×10−8 | 8.25×10−4 | C10orf54 | ↓ |
cg14313916 | 8 | 8,640,017 | intergenic | 2.61×10−8 | 1.00×10−3 | ↑ | |
cg15948245 | 7 | 104,581,746 | promoters | 2.72×10−8 | 1.00×10−3 | ↑ | |
cg21110873 | 12 | 131,712,414 | intergenic | 3.66×10−8 | 1.24×10−3 | ↑ | |
cg19550439 | 5 | 64,470,134 | introns | 4.64×10−8 | 1.47×10−3 | ADAMTS6 | ↑ |
cg23493751 | 3 | 46,204,787 | promoters | 5.86×10−8 | 1.65×10−3 | CCR3 | ↑ |
cg25814432 | 19 | 54,620,431 | introns | 5.97×10−8 | 1.65×10−3 | PRPF31 | ↑ |
cg17917920 | 7 | 93,220,788 | intergenic | 7.00×10−8 | 1.82×10−3 | ↑ | |
cg13501912 | 3 | 87,424,518 | intergenic | 7.72×10−8 | 1.90×10−3 | ↑ | |
cg06890950 | 4 | 81,382,711 | introns | 8.28×10−8 | 1.93×10−3 | C4orf22 | ↑ |
cg08041573 | 21 | 33,651,723 | intergenic | 8.72×10−8 | 1.93×10−3 | ↑ | |
cg03043928 | 11 | 2,085,203 | intergenic | 9.28×10−8 | 1.95×10−3 | ↑ | |
cg21002735 | 11 | 77,350,306 | intergenic | 9.85×10−8 | 1.98×10−3 | CLNS1A | ↑ |
cg07725198 | 1 | 27,229,130 | intergenic | 1.13×10−7 | 2.00×10−3 | GPATCH3 | ↑ |
cg09609314 | 2 | 174,147,631 | intergenic | 1.20×10−7 | 2.00×10−3 | ↑ | |
cg18677996 | 5 | 17,031,869 | intergenic | 1.25×10−7 | 2.00×10−3 | ↑ | |
cg10655371 | 7 | 91,749,682 | introns | 1.29×10−7 | 2.00×10−3 | CYP51A1 | ↑ |
cg20996620 | 7 | 20,623,878 | intergenic | 1.30×10−7 | 2.00×10−3 | ↑ | |
cg06931905 | 8 | 42,036,940 | intergenic | 1.35×10−7 | 2.00×10−3 | ↑ | |
cg00689014 | 17 | 39,869,138 | introns | 1.38×10−7 | 2.00×10−3 | JUP | ↑ |
cg13290719 | 4 | 58,063,449 | introns | 1.43×10−7 | 2.00×10−3 | IGFBP7-AS1 | ↑ |
cg10575940 | 17 | 75,365,389 | intergenic | 1.44×10−7 | 2.00×10−3 | ↑ | |
cg07561890 | 2 | 133,036,548 | intergenic | 1.45×10−7 | 2.00×10−3 | ↑ | |
cg16608672 | 5 | 30,346,809 | intergenic | 1.86×10−7 | 2.49×10−3 | ↑ | |
cg14446166 | 7 | 148,934,349 | intergenic | 2.05×10−7 | 2.60×10−3 | ↑ | |
cg27340958 | 4 | 7,755,730 | promoters | 2.19×10−7 | 2.60×10−3 | AFAP1-AS1 | ↑ |
cg26529712 | 19 | 35,399,253 | intergenic | 2.20×10−7 | 2.60×10−3 | ↑ | |
cg26879538 | 6 | 30,014,916 | introns | 2.21×10−7 | 2.60×10−3 | ZNRD1ASP | ↑ |
cg03318222 | 19 | 56,847,740 | introns | 2.24×10−7 | 2.60×10−3 | ZSCAN5A | ↑ |
cg21512370 | 13 | 48,990,327 | introns | 2.34×10−7 | 2.65×10−3 | LPAR6 | ↑ |
cg12447346 | 1 | 161,055,663 | introns | 2.45×10−7 | 2.70×10−3 | NECTIN4 | ↑ |
cg27616595 | 7 | 146,484,518 | intergenic | 2.77×10−7 | 2.98×10−3 | ↑ | |
cg01481116 | 11 | 93,867,992 | introns | 3.11×10−7 | 3.27×10−3 | PANX1 | ↑ |
cg14519534 | 7 | 102,082,149 | introns | 3.32×10−7 | 3.36×10−3 | ORAI2 | ↑ |
cg24620463 | 7 | 95,917,902 | intergenic | 3.35×10−7 | 3.36×10−3 | ↑ | |
cg20185525 | 17 | 41,278,712 | introns | 3.54×10−7 | 3.48×10−3 | BRCA1 | ↑ |
cg21775279 | 1 | 28,285,385 | exons | 3.71×10−7 | 3.56×10−3 | SMPDL3B | ↓ |
cg03169557 | 16 | 89,598,950 | exons | 4.05×10−7 | 3.80×10−3 | SPG7 | ↓ |
cg02180296 | 14 | 24,404,306 | intergenic | 4.24×10−7 | 3.90×10−3 | DHRS4-AS1 | ↑ |
cg02312525 | 22 | 50,525,778 | intergenic | 4.48×10−7 | 4.04×10−3 | MLC1 | ↑ |
cg19988798 | 5 | 175,511,300 | intergenic | 4.58×10−7 | 4.05×10−3 | ↑ |
The nearest annotated gene within ±5kb of the CpG probe
↑ indicates hyper-variability (increased variability in subjects with higher neuropathological burden as compared to those with lower burden), and ↓ indicates hypo-variability (decreased variability in subjects with higher neuropathological burden as compared to those with lower burden).